Medical breakthrough: for multiple sclerosis
On 14 November 2011, it was announced that trials into a new drug, alemtuzumab, have been successful - a significant development for those suffering from multiple sclerosis (MS).
The Freemasons’ Grand Charity gave £100,000 towards this research in 2010, at the University of Cambridge.
For further information:
